Home › Research › Biomarkers
Comparison of three plasma p-tau217 assays to detect PET-confirmed Alzheimer's pathologies
Sayo Matsuura, Kenji Tagai, Harutsugu Tatebe, Ryoji Goto, Hideki Matsumoto, Asaka Oyama, Yuki Momota, Masanori Ichihashi et al.. Alzheimer's & dementia (Amsterdam, Netherlands), 2026-03-04
Topic: Plasma and spinal-fluid biomarkers
Plain-language summary
All assays distinguished amyloid-positive from -negative individuals with high accuracy (89%-95%). Simoa showed superior sensitivity, Ella the smallest gray zone in a two-cutoff framework, and Lumipulse strongest tau correlation (r = 0.770). Multiple regression revealed higher amyloid β-values for Simoa/Ella (0.420-0.518) and higher tau β-values for Lumipulse (0.630). All platforms detected elevated p-tau217 in amyloid-positive individuals with substantial tau pathology despite relatively low Centiloid. All platforms accurately detect AD with platform-specific differences, which inform platform selection for clinical and research applications. TRIAL REGISTRATION: Clinical Trial Registration: UMIN Clinical Trials Registry (UMIN-CTR), Trial ID: UMIN000057548, Registration Date: April 8, 2025.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Matsuura, S., Tagai, K., Tatebe, H., Goto, R., Matsumoto, H., Oyama, A., et al. (2026). Comparison of three plasma p-tau217 assays to detect PET-confirmed Alzheimer's pathologies. Alzheimer's & dementia (Amsterdam, Netherlands). https://doi.org/10.1002/dad2.70294
Vancouver
Matsuura S, Tagai K, Tatebe H, Goto R, Matsumoto H, Oyama A, et al. Comparison of three plasma p-tau217 assays to detect PET-confirmed Alzheimer's pathologies. Alzheimer's & dementia (Amsterdam, Netherlands). 2026. doi:10.1002/dad2.70294. PMID: 41788190.
BibTeX
@article{matsuura2026-41788190,
author = {Matsuura, Sayo and Tagai, Kenji and Tatebe, Harutsugu and Goto, Ryoji and Matsumoto, Hideki and Oyama, Asaka and Momota, Yuki and Ichihashi, Masanori and others},
title = {{Comparison of three plasma p-tau217 assays to detect PET-confirmed Alzheimer's pathologies}},
journal = {Alzheimer's \& dementia (Amsterdam, Netherlands)},
year = {2026},
doi = {10.1002/dad2.70294},
pmid = {41788190},
url = {https://doi.org/10.1002/dad2.70294}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- All assays distinguished amyloid-positive from -negative individuals with high accuracy (89%-95%).
- Simoa showed superior sensitivity, Ella the smallest gray zone in a two-cutoff framework, and Lumipulse strongest tau correlation (r = 0.770).
- Multiple regression revealed higher amyloid β-values for Simoa/Ella (0.420-0.518) and higher tau β-values for Lumipulse (0.630).
- All platforms detected elevated p-tau217 in amyloid-positive individuals with substantial tau pathology despite relatively low Centiloid.
- All platforms accurately detect AD with platform-specific differences, which inform platform selection for clinical and research applications.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Participants113
- Evidence strengthLow
How this study scored 57/100
Published in a leading specialty journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record, multicenter collaboration and free to read, so those were left out: it earned 32 of the 56 points we could judge it on, which is 57 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Alzheimer's & dementia (Amsterdam, Netherlands)) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 2 / 4 | 113 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41788190) |
| Free to read | — / 2 | Access not recorded — left out of this score |
| Points | 32 / 56 | Scored on 10 of 20 parts. We have no data for the rest, so they are left out: 32 of the 56 points we could judge it on is 57 out of 100. |
| Total | 57 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Biomarkers from nearby years
Also tagged “18f”
318 studies in the library carry the topic tag “18f”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 318 tagged studies.